Madrigal Pharmaceuticals (MDGL) Other Working Capital Changes (2010 - 2026)

Madrigal Pharmaceuticals (MDGL) has 17 years of Other Working Capital Changes data on file, last reported at $40.6 million in Q1 2026.

• Other Working Capital Changes for Q1 2026 came in at $40.6 million, up 329.88% year-over-year; the trailing twelve-month figure through Mar 2026 was $65.2 million (up 608.28% YoY), and the FY2025 annual result was $34.0 million, up 219.84% from the prior year.
• Other Working Capital Changes advanced to $40.6 million in Q1 2026 per MDGL's latest filing, from -$1.5 million in the prior quarter.
• Over five years, Other Working Capital Changes peaked at $40.6 million in Q1 2026 and troughed at -$9.3 million in Q3 2025.
• A 5-year average of $5.1 million and a median of $928000.0 in 2024 frame the typical range for Other Working Capital Changes.
• On a YoY basis, Other Working Capital Changes climbed as much as 10096.61% in 2024 and fell as far as 22209.38% in 2024.
• A 5-year view of Other Working Capital Changes shows it stood at -$1.3 million in 2022, then jumped by 102.42% to $32000.0 in 2023, then sank by 22209.38% to -$7.1 million in 2024, then jumped by 78.45% to -$1.5 million in 2025, then surged by 2765.51% to $40.6 million in 2026.
• Business Quant data shows MDGL's Other Working Capital Changes at $40.6 million in Q1 2026, -$1.5 million in Q4 2025, and -$9.3 million in Q3 2025.